Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-573P (RNA, U6 small nuclear 573, pseudogene) is a **pseudogene** of the U6 small nuclear RNA (snRNA) family located on human chromosome 4[6]. Unlike functional U6 snRNA genes, which encode a non-coding RNA essential for catalyzing pre-mRNA splicing within the spliceosome[3][5], RNU6-573P is classified as a pseudogene, meaning it is a **non-functional genomic sequence** that resembles the functional gene but does not produce an active RNA product[1][6]. Small nuclear RNA U6 is normally involved in the **post-transcriptional modification** of pre-mRNAs through splicing, and its sequence is highly conserved and crucial for the spliceosomal complex[3][5]. However, **RNU6-573P does not encode a functional snRNA** and is not known to have a direct biological or therapeutic role. Pseudogenes like RNU6-573P may occasionally serve as sources of regulatory RNAs or interact with microRNA/piRNA pathways in specific contexts, but no direct interactions, disease roles, or drug associations are known for RNU6-573P in the biomedical literature[4]. **Summary:** RNU6-573P is a **pseudogene of a non-coding small nuclear RNA**, not an active gene, enzyme, receptor, or therapeutic target. It does not have established therapeutic, diagnostic, or biological function beyond being a remnant of genome evolution and is not associated with known drugs, mechanisms of action, or disease biomarker status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 573, pseudogene (RNU6-573P).